Scientists at the University of Leeds, alongside researchers at Roche Diagnostics, have recently developed a technique using artificial intelligence (AI) that could help treat patients with bowel cancer.
Indeed, the researchers used samples from a previous trial funded by Cancer Research UK to examine the levels of the two proteins with are often produced by this type of cancer – AREG and EREG. By determining the levels of these proteins, doctors can successfully use a particular treatment that impedes the growth of a third protein called EGRF.
The AI test will then help to determine the level of the two proteins, allowing providers to find the best treatment for each patient and identify cancer earlier.
The study was funded by Innovate UK and Roche Diagnostics and Yorkshire Cancer Research.